ad

Sunil Healthcare Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Posted by : Ekta Dhawan | Fri Feb 06 2026

Sunil Healthcare Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Sunil Healthcare’s Q3 results FY26 are scheduled to be announced on 6th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Sunil Healthcare Q3 Results 2026 Preview

  • Sunil Healthcare’s revenue is expected to be in the range of ₹526 crore, a 4% YoY increase. 
  • Profit After Tax, or PAT, is projected to fall 1.42% YoY. 
  • Net profit is ₹332.24 crore, down 1.42% YoY 
  • EBITDA to fall 30.66%

Sunil Healthcare Share Performance 

  • Over the past six months, Sunil Healthcare’s share price has fallen by 6.21% to ₹1,515.00.
  • Moreover, over the past year, the stock has decreased by 11.46%.
  • Despite this weak short-term performance, Sunil Healthcare’s stock has delivered a financially sound 4.27% return over the past 5 years.
  • As of 5th February 2026, the stock traded at ₹1,500.00 per share.

Key Factors to Watch for Sunil Healthcare Q3 Results FY26 

  1. Revenue & Sales Growth – Look at whether quarterly sales continue to grow compared with prior periods, as recent quarters showed improved sales around ~₹23–24 cr.
  2. Profitability Trends – Track net profit, operating profit and margins, since the company recently returned to profit after earlier losses.
  3. Operating Efficiency – Operating margin trends (e.g., OPM%) and cost control metrics indicate how well expenses are managed amid fluctuating sales.
  4. Debt & Financial Health – Assess leverage and ability to service debt, as elevated debt ratios and working capital pressures have been concerns.
  5. Cash Flow & Receivables – Operating cash flow levels and debtor turnover will signal liquidity and working capital efficiency, important for sustainability.

Final Thoughts

Sunil Healthcare will announce its Q3 FY26 results on 6th February 2026. Analysts expect 2.22% revenue growth, a 1.42% fall in PAT, and a 15% fall in EBITDA. Sunil Healthcare focuses on *driving sales growth across plastic and lifestyle furniture, improving profitability through cost and product mix, expanding retail and distribution reach, managing raw material costs, and enhancing market share with new product offerings

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Goodyear India Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Hindustan Copper Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Maral Overseas Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Nilkamal Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Shree Cement Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here

Sonata Software Gears Up for Q3 Reveal on 6th February; Check Key Expectations Here